CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Jintanat Ananworanich, Angèle Gayet-Ageron, Michelle Le Braz, Wisit Prasithsirikul, Ploenchan Chetchotisakd, Sasisopin Kiertiburanakul, Warangkana Munsakul, Phitsanu Raksakulkarn, Somboon Tansuphasawasdikul, Sunee Sirivichayakul, Matthias Cavassini, Urs Karrer, Daniel Genné, Reto Nüesch, Pietro Vernazza, Enos Bernasconi, Dominic Leduc, Claudette Satchell, Sabine Yerly, Luc Perrin, Andrew Hill, Thomas Perneger, Praphan Phanuphak, Hansjakob Furrer, David Cooper, Kiat Ruxrungtham, Bernard Hirschel
  • The Lancet, August 2006, Elsevier
  • DOI: 10.1016/s0140-6736(06)69153-8
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Angèle Gayet-Ageron